AI Used in Specialty-Level, Primary Care Disease Diagnosis
An ophthalmologist at the University of Iowa has designed a system to safely identify diabetic retinopathy without needing human interpretation of results. The system, which uses artificial intelligence (AI), has earned FDA (Food and Drug Administration) authorization following a clinical trial in primary care offices. Study results, first published online in Nature Digital Medicine in…